Free Access
Vet. Res.
Volume 36, Number 2, March-April 2005
Page(s) 257 - 262
How to cite this article Vet. Res. (2005) 257-262
References of Vet. Res. 36 (2005) 257-262
  1. Barton M.H., Collatos C., Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease, J. Vet. Intern. Med. 13 (1999) 457-464 [CrossRef] [PubMed].
  2. Bertoni G., Improved bioassay for the detection of porcine tumor necrosis factor using a homologous cell line: PK (15), J. Immunol. Methods 160 (1993) 267-271 [CrossRef] [PubMed].
  3. Bull S., Langezaal I., Clothier R., Coecke S., A genetically engineered cell-based system for detecting metabolism-mediated toxicity, Altern. Lab. Anim. 29 (2001) 703-716 [PubMed].
  4. Giraud O., Seince P.F., Rolland C., Lecon-Malas V., Desmonts J.M., Aubier M., Dehoux M., Halothane reduces the early lipopolysaccharide-induced lung inflammation in mechanically ventilated rats, Am. J. Respir. Crit. Care Med. 162 (2000) 2278-2286 [PubMed].
  5. Kawasaki T., Ogata M., Kawasaki C., Ogata J., Inoue Y., Shigematsu A., Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro, Anesth. Analg. 89 (1999) 665-669 [CrossRef] [PubMed].
  6. Kohrs R., Durieux M.E., Ketamine: teaching an old drug new tricks, Anesth. Analg. 87 (1998) 1186-1193 [CrossRef] [PubMed].
  7. Larsen B., Hoff G., Wilhelm W., Buchinger H., Wanner G.A., Bauer M., Effect of intravenous anesthetics on spontaneous and endotoxin-stimulated cytokine response in cultured human whole blood, Anesthesiology 89 (1998) 1218-1227 [CrossRef] [PubMed].
  8. Morris D.D., Endotoxemia in horses: a review of cellular and humoral mediators involved in its pathogenesis, J. Vet. Intern. Med. 5 (1991) 167-181 [PubMed].
  9. Morris D.D., Crowe N., Moore J.N., Moldawer L.L., Endotoxin-induced production of interleukin 6 by equine peritoneal macrophages in vitro, Am. J. Vet. Res. 53 (1992) 1298-1301 [PubMed].
  10. Mosman T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55-63 [CrossRef] [PubMed].
  11. Muir W.W., Sams R., Effects of ketamine infusion on halothane minimal alveolar concentration in horses, Am. J. Vet. Res. 53 (1992) 1802-1806 [PubMed].
  12. Muir W.W., Skarda R.T., Milne D.W., Evaluation of xylazine and ketamine hydrochloride for anesthesia in horses, Am. J. Vet. Res. 38 (1977) 195-201 [PubMed].
  13. Okada H., Detection of Interleukin-1 and Interleukin-6 on cryopreserved bovine mammary epithelial cells in vitro, J. Vet. Med. Sci. 59 (1997) 503-507 [CrossRef] [PubMed].
  14. Reves J.G., Glass P.S.A., Lubarsky D.A., Nonbarbiturate intravenous anesthetics, in: Miller R.D. (Ed.), Anesthesia, Churchill Livingstone, New York, 2000, pp. 228-272.
  15. Takenaka I., Ogata M., Koga K., Matsumoto T., Shigematsu A., Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice, Anesthesiology 80 (1994) 402-408 [CrossRef] [PubMed].
  16. Taniguchi T., Shibata K., Yamamoto K., Ketamine inhibits endotoxin-induced shock in rats, Anesthesiology 95 (2001) 928-932 [CrossRef] [PubMed].
  17. Wang S., Yan L., Wesley R.A., Danner R.L., Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP, J. Biol. Chem. 272 (1997) 5959-5965 [CrossRef] [PubMed].
  18. Waterman A.E., Robertson S.A., Lane J.G., Pharmacokinetics of intravenously administered ketamine in the horse, Res. Vet. Sci. 42 (1987) 162 [PubMed] -166.
  19. Weigand M.A., Schmidt H., Zhao Q., Plaschke K., Martin E., Bardenheuer H.J., Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro, Anesth. Analg. 90 (2000) 206-212 [CrossRef] [PubMed].
  20. Werners A.H., Bull S., Fink-Gremmels J., Bryant C.E., Generation and characterization of an equine macrophage cell line (e-CAS cells) derived from equine bone marrow cells, Vet. Immunol. Immunopathol. 97 (2004) 65-76 [PubMed].
  21. Yu Y., Zhou Z., Xy J., Liu Z., Wang Y., Ketamine reduces NF-kappa-B activation and TNF-alpha production in rat mononuclear cells induced by lipopolysaccharide in vitro, Ann. Clin. Lab. Sci. 32 (2002) 292-298 [PubMed].